Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AORT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Andrew M. Green SVP, Regulatory and Quality | AORT Artivion, Inc. | Sale | 11,480 | $24.97 | $286.7K Sale | Form 4 ↗ |
| Sep 3, 2026 | Andrew M. Green SVP, Regulatory and Quality | AORT Artivion, Inc. | Sale | 1,493 | $26.02 | $38.8K Sale | Form 4 ↗ |
| Sep 2, 2026 | Andrew M. Green SVP, Regulatory and Quality | AORT Artivion, Inc. | Sale | 6,510 | $27.27 | $177.5K Sale | Form 4 ↗ |
| Aug 19, 2026 | James P. Mackin President & CEO | AORT Artivion, Inc. | Sale | 70,000 | $28.96 | $2.0M Sale | Form 4 ↗ |
| Aug 14, 2026 | Andrew M. Green SVP, Regulatory and Quality | AORT Artivion, Inc. | Sale | 616 | $28.55 | $17.6K Sale | Form 4 ↗ |
| Aug 14, 2026 | Lance A. Berry EVP, COO, CFO & Treasurer | AORT Artivion, Inc. | Sale | 715 | $28.55 | $20.4K Sale | Form 4 ↗ |
| Aug 12, 2026 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 977 | $28.49 | $27.8K Sale | Form 4 ↗ |
| Jun 11, 2026 | Andrew M. Green SVP, Regulatory and Quality | AORT Artivion, Inc. | Sale | 30,000 | $20.69 | $620.7K Sale | Form 4 ↗ |
| Jun 11, 2026 | Andrew M. Green SVP, Regulatory and Quality | AORT Artivion, Inc. | Sale | 14,001 | $20.71 | $290.0K Sale | Form 4 ↗ |
| Mar 4, 2026 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 8,962 | $38.00 | $340.6K Sale | Form 4 ↗ |
| Mar 3, 2026 | Amy Horton VP, Chief Accounting Officer | AORT Artivion, Inc. | Sale | 901 | $37.78 | $34.0K Sale | Form 4 ↗ |
| Mar 3, 2026 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 3,843 | $37.78 | $145.2K Sale | Form 4 ↗ |
| Mar 3, 2026 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 2,149 | $37.78 | $81.2K Sale | Form 4 ↗ |
| Mar 3, 2026 | John E. Davis Chief Commercial Officer | AORT Artivion, Inc. | Sale | 4,573 | $37.78 | $172.8K Sale | Form 4 ↗ |
| Mar 3, 2026 | Lance A. Berry EVP, COO, CFO & Treasurer | AORT Artivion, Inc. | Sale | 6,316 | $37.78 | $238.6K Sale | Form 4 ↗ |
| Mar 3, 2026 | James P. Mackin President & CEO | AORT Artivion, Inc. | Sale | 17,887 | $37.78 | $675.8K Sale | Form 4 ↗ |
| Mar 2, 2026 | Amy Horton VP, Chief Accounting Officer | AORT Artivion, Inc. | Sale | 641 | $38.02 | $24.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 1,513 | $38.02 | $57.5K Sale | Form 4 ↗ |
| Mar 2, 2026 | James P. Mackin President & CEO | AORT Artivion, Inc. | Sale | 14,911 | $38.02 | $566.9K Sale | Form 4 ↗ |
| Mar 2, 2026 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 2,183 | $38.02 | $83.0K Sale | Form 4 ↗ |
| Mar 2, 2026 | Lance A. Berry EVP, COO, CFO & Treasurer | AORT Artivion, Inc. | Sale | 5,178 | $38.02 | $196.9K Sale | Form 4 ↗ |
| Mar 2, 2026 | John E. Davis Chief Commercial Officer | AORT Artivion, Inc. | Sale | 2,784 | $38.02 | $105.8K Sale | Form 4 ↗ |
| Feb 24, 2026 | Amy Horton VP, Chief Accounting Officer | AORT Artivion, Inc. | Sale | 830 | $35.69 | $29.6K Sale | Form 4 ↗ |
| Feb 24, 2026 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 1,259 | $35.69 | $44.9K Sale | Form 4 ↗ |
| Feb 24, 2026 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 1,668 | $35.69 | $59.5K Sale | Form 4 ↗ |
| Feb 24, 2026 | James P. Mackin President & CEO | AORT Artivion, Inc. | Sale | 13,936 | $35.69 | $497.4K Sale | Form 4 ↗ |
| Feb 24, 2026 | Lance A. Berry EVP, COO, CFO & Treasurer | AORT Artivion, Inc. | Sale | 4,485 | $35.69 | $160.1K Sale | Form 4 ↗ |
| Feb 24, 2026 | John E. Davis Chief Commercial Officer | AORT Artivion, Inc. | Sale | 2,075 | $35.69 | $74.1K Sale | Form 4 ↗ |
| Feb 23, 2026 | Amy Horton VP, Chief Accounting Officer | AORT Artivion, Inc. | Sale | 1,731 | $37.59 | $65.1K Sale | Form 4 ↗ |
| Feb 23, 2026 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 2,423 | $37.59 | $91.1K Sale | Form 4 ↗ |
| Feb 23, 2026 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 3,079 | $37.59 | $115.7K Sale | Form 4 ↗ |
| Feb 23, 2026 | James P. Mackin President & CEO | AORT Artivion, Inc. | Sale | 20,962 | $37.59 | $788.0K Sale | Form 4 ↗ |
| Feb 23, 2026 | Lance A. Berry EVP, COO, CFO & Treasurer | AORT Artivion, Inc. | Sale | 4,981 | $37.59 | $187.2K Sale | Form 4 ↗ |
| Feb 23, 2026 | John E. Davis Chief Commercial Officer | AORT Artivion, Inc. | Sale | 3,773 | $37.59 | $141.8K Sale | Form 4 ↗ |
| Dec 15, 2025 | John E. Davis Chief Commercial Officer | AORT Artivion, Inc. | Sale | 5,000 | $45.11 | $225.6K Sale | Form 4 ↗ |
| Dec 8, 2025 | Amy Horton VP, Chief Accounting Officer | AORT Artivion, Inc. | Sale | 4,572 | $44.42 | $203.1K Sale | Form 4 ↗ |
| Dec 3, 2025 | James P. Mackin President & CEO | AORT Artivion, Inc. | Sale | 30,921 | $45.46 | $1.4M Sale | Form 4 ↗ |
| Dec 3, 2025 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 5,267 | $45.30 | $238.6K Sale | Form 4 ↗ |
| Dec 3, 2025 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 2,048 | $45.30 | $92.8K Sale | Form 4 ↗ |
| Dec 2, 2025 | James P. Mackin President & CEO | AORT Artivion, Inc. | Sale | 30,921 | $45.56 | $1.4M Sale | Form 4 ↗ |
| Nov 21, 2025 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 8,370 | $45.35 | $379.6K Sale | Form 4 ↗ |
| Nov 21, 2025 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 18,705 | $44.91 | $840.0K Sale | Form 4 ↗ |
| Nov 21, 2025 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 5,715 | $45.35 | $259.2K Sale | Form 4 ↗ |
| Nov 21, 2025 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 14,586 | $44.92 | $655.2K Sale | Form 4 ↗ |
| Nov 20, 2025 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 1,355 | $44.28 | $60.0K Sale | Form 4 ↗ |
| Nov 20, 2025 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 2,033 | $44.32 | $90.1K Sale | Form 4 ↗ |
| Nov 20, 2025 | Marshall S. Stanton SVP, Clinical & MD Affair | AORT Artivion, Inc. | Sale | 11,888 | $44.14 | $524.7K Sale | Form 4 ↗ |
| Nov 18, 2025 | Elizabeth A. Hoff Director | AORT Artivion, Inc. | Sale | 4,200 | $45.10 | $189.4K Sale | Form 4 ↗ |
| Nov 17, 2025 | Jean F. Holloway SVP, General Counsel | AORT Artivion, Inc. | Sale | 6,394 | $45.17 | $288.8K Sale | Form 4 ↗ |
| Nov 17, 2025 | John E. Davis Chief Commercial Officer | AORT Artivion, Inc. | Sale | 6,394 | $45.17 | $288.8K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:05 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances